Development of fluorescence-linked immunosorbent assay for rapid detection of Staphylococcus aureus

Appl Microbiol Biotechnol. 2024 Dec;108(1):2. doi: 10.1007/s00253-023-12836-2. Epub 2023 Dec 28.

Abstract

Staphylococcus aureus is a major pathogen that causes infections and life-threatening diseases. Although antibiotics, such as methicillin, have been used, methicillin-resistant S. aureus (MRSA) causes high morbidity and mortality rates, and conventional detection methods are difficult to be used because of time-consuming process. To control the spread of S. aureus, a development of a rapid and simple detection method is required. In this study, we generated a fluorescent anti-S. aureus antibody, and established a novel fluorescence-linked immunosorbent assay (FLISA)-based S. aureus detection method. The method showed high sensitivity and low limit of detection toward MRSA detection. The assay time for FLISA was 5 h, which was faster than that of conventional enzyme-linked immunosorbent assay (ELISA) or rapid ELISA. Moreover, the FLISA-based detection method was applied to diagnose clinically isolated MRSA samples that required only 5.3 h of preincubation. The FLISA method developed in this study can be widely applied as a useful tool for convenient S. aureus detection. KEY POINTS: • A fluorescence-linked immunosorbent assay-based S. aureus detection method • Simultaneous quantification of a maximum of 96 samples within 5 h • Application of the novel system to diagnosis clinical isolates.

Keywords: ELISA; FLISA; Fluorescent antibody; Immunoassay; Staphylococcus aureus.

MeSH terms

  • Antibodies
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunosorbents
  • Methicillin-Resistant Staphylococcus aureus*
  • Staphylococcal Infections* / diagnosis
  • Staphylococcus aureus

Substances

  • Immunosorbents
  • Antibodies